Form D · Pharmaceuticals
Prexa Pharmaceuticals Inc
Boston, MA · CIK 0001381209
Offering snapshot reported Apr 29, 2011 · SEC filing
- Reported sold
- $3.26M Offering amount: $7.01M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 15, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 29, 2011 | Initial | $3,257,173 | No comparison | 4 | SEC filing |
| Nov 9, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-159077
Source: Form D, filed Apr 29, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Bednarski | Director |
| Charles M Cohen | Director, Executive |
| Jason Fisherman | Director |
| Evelyn Graham | Director, Executive |
| Thomas Needham | Director, Executive |
| Brian Piper | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
184 High Street, 4 Th Floor
Boston, MA, 02110
Boston, MA, 02110